Skip to main content
Log in

Reduced haloperidol: Effects on striatal dopamine metabolism and conversion to haloperidol in the rat

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript


Acute injection of rats with either haloperidol or reduced haloperidol (1 mg/kg, IP) greatly increased the striatal concentrations of the acidic dopamine metabolites, indicating enhanced turnover of dopamine. The effect of reduced haloperidol was almost as great as that of haloperidol. Reduced haloperidol, however, was much less efficient (about 400 times) than haloperidol in displacing [3H]spiperone binding to striatal membranes in vitro. In agreement with the above results, reduced haloperidol was found to be oxidized to haloperidol, so that 2 h after injection of reduced haloperidol the concentrations of haloperidol and reduced haloperidol were equal in the striatum. The apparent conversion of reduced haloperidol to haloperidol was much quicker in liver than in plasma or brain, and it is suggested that the conversion primarily occurs in the liver. Before drawing any definite conclusion about the possible central activity of reduced haloperidol, further studies with other animal species are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  • Braun GA, Poos GI, Soudijn W (1967) Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. Eur J Pharmacol 1:58–62

    Google Scholar 

  • Carlsson A (1978) Mechanism of action of neuroleptic drugs. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1057–1070

    Google Scholar 

  • Creese I, Snyder SH (1977) A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood. Nature 270:180–182

    Google Scholar 

  • Forsman A, Larssen M (1978) Metabolism of haloperidol. Curr Ther Res 24:567–568

    Google Scholar 

  • Forsman A, Fölsch G, Larsson M, Öhman R (1977) On the metabolism of haloperidol in man. Curr Ther Res 21:606–617

    Google Scholar 

  • Korpi ER, Phelps BH, Granger H, Chang W-H, Linnoila M, Meek JL, Wyatt RJ (1983a) Simultaneous determination of haloperidol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection. Clin Chem 29:624–628

    Google Scholar 

  • Korpi ER, Kleinman JE, Costakos DT, Linnoila M, Wyatt RJ (1983b) Reduced haloperidol in the postmortem brains of haloperidol treated patients. Psychiatry Res (in press)

  • Nielsen JA, Johnston CA (1982) Rapid, concurrent analysis of dopamine, 5-hydroxytryptamine, their precursors and metabolites utilizing high performance liquid chromatography with electrochemical detection: analysis of brain tissue and cerebrospinal fluid. Life Sci 31:2847–2856

    Google Scholar 

  • Scheinin M, Chang W-H, Kirk KL, Linnoila M (1983) Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. Anal Biochem 131:246–253

    Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Korpi, E.R., Wyatt, R.J. Reduced haloperidol: Effects on striatal dopamine metabolism and conversion to haloperidol in the rat. Psychopharmacology 83, 34–37 (1984).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

Key words